EUVIMEDEUVIMED entdecken
Crossref

Comprehensive Inhibition of Breast Cancer Progression Through CD39 Targeting and Paclitaxel: Modulating Cell Proliferation, Apoptosis, and Migration

Sahand Eslami, Mahya Ahmadpour Youshanlui, Amir Baghbanzadeh, Fereshteh Jamali, Behzad Baradaran

Current Genetic Medicine Reports · 14.03.2026 · 14 (1)

DOI: 10.1007/s40142-026-00243-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Genetic Medicine Reports, online erschienen am 14.03.2026. Verfasst von Sahand Eslami und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Eslami, S., Youshanlui, M. A., Baghbanzadeh, A., Jamali, F., & Baradaran, B. (2026). Comprehensive Inhibition of Breast Cancer Progression Through CD39 Targeting and Paclitaxel: Modulating Cell Proliferation, Apoptosis, and Migration. Current Genetic Medicine Reports, 14(1). https://doi.org/10.1007/s40142-026-00243-8

Vancouver

Eslami S, Youshanlui MA, Baghbanzadeh A, Jamali F, Baradaran B. Comprehensive Inhibition of Breast Cancer Progression Through CD39 Targeting and Paclitaxel: Modulating Cell Proliferation, Apoptosis, and Migration. Current Genetic Medicine Reports. 2026;14(1). doi:10.1007/s40142-026-00243-8

BibTeX
@article{Eslami2026,
  author = {Eslami, Sahand and Youshanlui, Mahya Ahmadpour and Baghbanzadeh, Amir and Jamali, Fereshteh and Baradaran, Behzad},
  title = {Comprehensive Inhibition of Breast Cancer Progression Through CD39 Targeting and Paclitaxel: Modulating Cell Proliferation, Apoptosis, and Migration},
  journal = {Current Genetic Medicine Reports},
  year = {2026},
  volume = {14},
  number = {1},
  doi = {10.1007/s40142-026-00243-8}
}
Kostenlos starten →